Speaker illustration

Professor Francesco Cosentino

Karolinska University Hospital, Stockholm (Sweden)

Member of:

European Society of Cardiology

Francesco Cosentino is professor of Cardiology at the Karolinska Institute and University Hospital in Stockholm. Medical school and specialty training at the University of Rome. Cardiovascular Fellowship at the Mayo Clinic & Foundation, Rochester, MN, USA where he also obtained PhD in Cardiovascular Pharmacology. Former “lecturer” and “titular professor” of Cardiology at the University Hospital of Zurich. Former associate professor of Cardiology, University of Rome “Sapienza”. Prof. Cosentino is vice-president of the European Society of Cardiology. Chairman of the ESC Partnership and Policy Committee. He chaired 2019 ESC Guidelines on Diabetes and Cardiovascular Disease. He is deputy editor of European Heart Journal and consulting editor of Cardiovascular Research Journal. He is the recipient of grants and prizes from national and international research councils and private foundations. He is the leading author of more than 200 original articles in top-ranking, peer-reviewed journals

How to protect the kidney in patients with diabetes and heart disease

Event: ESC Congress 2024

Topic: Renal Failure and Cardiovascular Disease

Session type: Symposium

Thumbnail

Guidelines in Practice: the 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes

Event: ESC Preventive Cardiology 2024

Topic: Diabetes

Session type: Guidelines in Practice

Thumbnail

Precision medicine for preventing cardiovascular disease in diabetes

Event: ESC Congress 2023

Topic: Cardiovascular Disease in Special Populations

Session type: Official Joint Session

Thumbnail

Cardiopolicy pioneers – how to restore funding for cardiovascular health

Event: ESC Congress 2023

Topic: Other

Session type: Special Session

Thumbnail

Meet the Experts: how to lower cardiovascular disease risk in patients with diabetes

Event: ESC Congress 2022

Topic: Cardiovascular Pharmacotherapy

Session type: Meet the Experts

Thumbnail

How do SGLT2 inhibitors act in heart failure?

Event: ESC Congress 2022

Topic: Cardiovascular Pharmacotherapy

Session type: Symposium

Thumbnail

Essentials of diabetes management for clinicians

Event: ESC Preventive Cardiology 2022

Topic: Diabetes and the Heart

Session type: Special Session

Thumbnail

Great Debate: metformin – still first-line therapy in type 2 diabetes and heart disease?

Event: ESC Congress 2021 - The Digital Experience

Topic: Risk Factors and Prevention

Session type: Great Debates

Thumbnail

Important aspects of cardiovascular disease in patients with diabetes

Event: ESC Congress 2021 - The Digital Experience

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Session type: Official Joint Session

Thumbnail

SGLT2i in heart failure

Event: Heart Failure 2021

Topic: Chronic Heart Failure

Session type: Special Session

Thumbnail